Ronald D Barber, MD | |
1201 Health Center Pkwy, Yukon, OK 73099-6381 | |
(405) 717-6851 | |
Not Available |
Full Name | Ronald D Barber |
---|---|
Gender | Male |
Speciality | Emergency Medicine - Emergency Medical Services |
Location | 1201 Health Center Pkwy, Yukon, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568567170 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207PE0004X | Emergency Medicine - Emergency Medical Services | 15264 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ronald D Barber, MD Po Box 268893, Oklahoma City, OK 73126-8893 Ph: (866) 324-0820 | Ronald D Barber, MD 1201 Health Center Pkwy, Yukon, OK 73099-6381 Ph: (405) 717-6851 |
News Archive
Protein supplements don't improve performance or recovery time and, according to a recent study, such supplements are inefficient for most athletes. "They are often poorly used or unnecessary by both high-level athletes and amateurs," says Martin Fr-chette, a researcher and graduate of the Universit- de Montr-al Department of Nutrition.
Aeterna Zentaris Inc. today announced that its Japanese partner, Yakult Honsha, has initiated a Phase 1/2 trial in Japan to assess the safety and efficacy of the Company's PI3K/Akt inhibitor, perifosine, in combination with chemotherapeutic agent, capecitabine, in patients with refractory advanced colorectal cancer ("CRC").
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV- (guanfacine) Extended Release Tablets, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, and Daytrana- (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
A team of researchers at the MedUni Vienna, together with scientists from the University Hospital of Freiburg, has decoded a mechanism in cyclic plant peptides, known as cyclotides, from the family of coffee plants (Rubiaceae) that could open up new possibilities for immune suppression.
A new study has shown that potent antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could help protect against COVID-19 infection. Preliminary results in animal studies have so far proven successful. The study titled, "Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model," was published in the latest issue of the journal Science.
› Verified 6 days ago
Heidi M. Metheny, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1201 Health Center Pkwy, Yukon, OK 73099 Phone: 405-717-6851 | |
Dora Cherian, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 529 Bluegrass Ln, Yukon, OK 73099 Phone: 405-924-1093 |